Patient-reported experience with the use of Mepitel Film for prevention of acute radiation dermatitis in breast cancer
Supportive Care in Cancer · 2024
DOI: 10.1007/s00520-023-08302-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Milena Gojsevic und 18 weiteren Autor:innen. Beteiligte Einrichtung: Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Breast Neoplasms, Radiodermatitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND AND PURPOSE: Mepitel Film (MF) has been demonstrated to reduce the severity of radiation dermatitis (RD) in patients receiving breast cancer radiotherapy (RT). The objective of this study was to characterize patient-reported experience with MF use, including its impact on daily activities and wellbeing. MATERIALS AND METHODS: This single-institution study analyzed anonymized responses to a questionnaire completed by patients who used MF for the prevention of RD during breast cancer RT. RESULTS: Of the 254 patients contacted, 192 patients completed the survey. Most patients disagreed or strongly disagreed that MF limited their ability to perform their daily activities, including household chores (88%, n = 169/191), their ability to work (83%, n = 157/189), or their ability to sleep (85%, n = 163/191). Furthermore, patients agreed or strongly agreed MF was comfortable on their skin (67%, n = 126/189) and protected their skin from rubbing against clothing (86%, n = 161/188). Some patients agreed or strongly agreed that MF affected their ability to shower (31%, n = 50/162), wear bras (28%, n = 51/185), and impacted their level of pruritus (35%, n = 67/189). However, most patients agreed or strongly agreed that their overall experience with MF was positive (92%, n = 173/189) and would recommend MF to a friend undergoing breast cancer RT (88%, n = 166/188). CONCLUSION: MF use is associated with positive patient-reported experience during breast RT with minimal impact on daily activities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
- Department of Radiation Therapy, University of Otago, Wellington, New Zealand.
- Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
- Lions Gate Hospital, North Vancouver, British Columbia, Canada.
- Division of Radiation Oncology, Allegheny General Hospital, Drexel University College of Medicine, Pittsburgh, PA, USA.
- Division of Radiation Oncology, West Cancer Center, Compass Oncology, Tigard, OR, USA.
Zitieren
APA
Gojsevic, M., Kennedy, S., Rajeswaran, T., Herst, P., Safavi, A. H., Corbin, K., Hill, R., Tran, W., Carothers, K., Gallant, F., Trombetta, M., Arscott, W. T., Shariati, S., Lam, J., Akkila, S., Behroozian, T., Zhang, E., Karam, I., & Chow, E. (2024). Patient-reported experience with the use of Mepitel Film for prevention of acute radiation dermatitis in breast cancer. Supportive Care in Cancer. https://doi.org/10.1007/s00520-023-08302-4
Vancouver
Gojsevic M, Kennedy S, Rajeswaran T, Herst P, Safavi AH, Corbin K, et al. Patient-reported experience with the use of Mepitel Film for prevention of acute radiation dermatitis in breast cancer. Supportive Care in Cancer. 2024. doi:10.1007/s00520-023-08302-4
BibTeX
@article{Gojsevic2024,
author = {Gojsevic, Milena and Kennedy, Samantha and Rajeswaran, Thenugaa and Herst, Patries and Safavi, Amir H and Corbin, Kimberly and Hill, Rosemary and Tran, William and Carothers, Katherine and Gallant, François and Trombetta, Mark and Arscott, William T and Shariati, Saba and Lam, Jacqueline and Akkila, Shereen and Behroozian, Tara and Zhang, Elwyn and Karam, Irene and Chow, Edward},
title = {Patient-reported experience with the use of Mepitel Film for prevention of acute radiation dermatitis in breast cancer},
journal = {Supportive Care in Cancer},
year = {2024},
doi = {10.1007/s00520-023-08302-4}
}
EUVIMED